About
Abe is a specialised biotech investor and incubator dedicated to developing treatments for Epidermolysis Bullosa (EB), particularly Dystrophic EB (DEB), a severe genetic skin disorder caused by a mutation in the COL7A1 gene. EB causes extremely fragile skin that blisters or tears with minimal friction, and it affects not only the skin but also internal organs such as the eyes, mouth, and oesophagus.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Sectors
- biotech
Contact Information
linkedin.com/in/••••••••
Find more investors like ABE
Search Investors